Tarrant County, Texas, and the surrounding areas have been grappling with a shortage of name-brand Adderall since October 2022, causing significant concern among those who rely on the medication to manage their attention-deficit/hyperactivity disorder (ADHD) symptoms.
Numerous pharmacies in Fort Worth have been grappling with supply chain issues that have left them unable to guarantee when their next shipment of the medication will arrive. The issue has affected a growing number of individuals, who have been turning to telemedicine and other alternative treatments amid the shortage.
ADHD is a neurological disorder that affects a significant portion of the population and can lead to low self-esteem, troubled relationships, and difficulty succeeding at school or work. The medication Adderall is a popular treatment option for many of these individuals, but the shortage has put a significant strain on their ability to manage their condition effectively.
The JPS Health Network’s pharmacy department has been monitoring the situation closely and has been able to fill prescriptions for patients’ urgent care use. However, they are also grappling with the shortage and have been forced to use multiple strengths of the medication or seek alternative treatment options in some cases.
The Food and Drug Administration has announced that the shortage is due to manufacturing delays and production issues at Teva, a drug company that produces both generic and brand-name Adderall. Other manufacturers, such as Epic Pharma LLC, are continuing to produce Adderall, but the current supply is not sufficient to meet demand.
Despite the shortage, the FDA recommends that patients speak with their healthcare providers to discuss alternative treatment options. However, the shortage has caused significant anxiety for those who rely on the medication to manage their symptoms.
One such individual is Fort Worth resident Laurie George, who has been struggling to refill her prescription amid the shortage. She worries about running out of the medication and the impact it will have on her ability to manage her ADHD symptoms.
As the shortage continues, it is essential to remain vigilant and stay in close communication with healthcare providers to ensure that those who rely on Adderall can continue to receive effective treatment.